MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC
Clinical trial NCT02369198 · COMPLETED
Trial details
- NCT number
- NCT02369198
- Sponsor
- Asbestos Diseases Research Foundation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2017-01-04
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.